PCM
EBS icon

Peregrine Capital Management’s Emergent Biosolutions EBS Stock Holding History

Peregrine Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-126,613
Closed -$6.34M – 341
2021
Q3 		$6.34M Sell
126,613
-24,387
-16% -$1.48M 0.13% 244
2021
Q2 		$9.51M Sell
151,000
-5,113
-3% -$328K 0.17% 238
2021
Q1 		$14.5M Sell
156,113
-20,778
-12% -$2.13M 0.27% 183
2020
Q4 		$15.8M Buy
176,891
+30,266
+21% +$2.78M 0.3% 140
2020
Q3 		$15.2M Sell
146,625
-73,463
-33% -$7.92M 0.4% 96
2020
Q2 		$17.4M Sell
220,088
-25,107
-10% -$1.87M 0.49% 75
2020
Q1 		$14.2M Sell
245,195
-52,850
-18% -$3.05M 0.51% 72
2019
Q4 		$16.1M Sell
298,045
-3,442
-1% -$187K 0.41% 113
2019
Q3 		$15.8M Sell
301,487
-22,398
-7% -$1.04M 0.43% 102
2019
Q2 		$15.6M Buy
323,885
+25,799
+9% +$1.24M 0.39% 114
2019
Q1 		$15.1M Buy
298,086
+30,346
+11% +$1.79M 0.38% 121
2018
Q4 		$15.9M Sell
267,740
-42,473
-14% -$2.74M 0.45% 89
2018
Q3 		$20.4M Sell
310,213
-19,407
-6% -$1.13M 0.48% 86
2018
Q2 		$16.6M Sell
329,620
-19,348
-6% -$1.01M 0.42% 110
2018
Q1 		$18.4M Sell
348,968
-17,202
-5% -$857K 0.45% 90
2017
Q4 		$17M Sell
366,170
-88,687
-19% -$3.73M 0.4% 101
2017
Q3 		$18.4M Buy
454,857
+131,692
+41% +$4.76M 0.44% 88
2017
Q2 		$11M Sell
323,165
-912
-0.3% -$28.2K 0.27% 154
2017
Q1 		$9.52M Buy
324,077
+22,232
+7% +$677K 0.24% 176
2016
Q4 		$9.91M Buy
+301,845
New +$9.05M 0.26% 179

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Peregrine Capital Management's EBS Position: Q4 2021 in Review

Peregrine Capital Management sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 126,613 shares — an estimated $6.34M sold.

Peregrine Capital Management first reported a position in EBS in Q4 2016 and held it in 20 quarters. The position peaked at $20.4M in Q3 2018. 253 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Peregrine Capital Management reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • Peregrine Capital Management sold 126,613 Emergent Biosolutions shares in Q4 2021, an estimated $6.34M.
  • Peregrine Capital Management first reported a position in Emergent Biosolutions in Q4 2016 and held it in 20 quarters.
  • Peregrine Capital Management's Emergent Biosolutions position peaked at $20.4M in Q3 2018.
  • 253 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Peregrine Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.